Case Report: Durable remission of intraocular mantle cell lymphoma after CD19 CAR-T therapy

Mantle cell lymphoma (MCL) is an aggressive B-cell neoplasm with poor prognosis in refractory relapse. Intraocular (vitreoretinal) involvement is extremely rare and represents a diagnostic and therapeutic challenge due to the immune-privileged status of the eye and the risk of central nervous system...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Álvaro Bienert-García, Carolina Arruabarrena, Mónica Asencio-Duran, Marta Morado Arias, Tycho Baumann, Antonia Rodriguez Izquierdo, José María Sánchez-Pina, Nieves López-Muñoz, Daniel Gil-Alós, Adolfo Jesús Saez-Marín, María Calbacho, Joaquín Martínez-López, Ana Jiménez-Ubieto
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2026-03-01
Serie:	Frontiers in Immunology
Soggetti:	brexucabtageneautoleucel CAR-T flow cytometry intraocular involvement mantle cell lymphoma vitrectomy
Accesso online:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1786040/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!